Literature DB >> 27655286

MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.

Zhao Xiaohong1, Fan Lichun1, Xie Na2, Zou Kejian3, Xiao Xiaolan4, Wang Shaosheng5.   

Abstract

MicroRNAs (miRNAs) play an important role in the tumorigenesis of ovarian cancer. Previously, we have reported the dysregulation of miR-203 in the ovarian cancer tissues. However, the biological functions and molecular mechanisms of miR-203 in ovarian cancer remain unknown. Here, we showed that the expression of miR-203 was increased in ovarian cancer tissues compared with the adjacent non-cancerous tissues and the transcription of miR-203 was inhibited by P53. Forced expression of miR-203 in ovarian cancer promoted cell growth and migration, while depletion of miR-203 inhibited the growth and migration of ovarian cancer cells. In addition, miR-203 promoted the metastasis of ovarian cancer cells in vivo and shorted the survival of the nude mice. Mechanically, miR-203 targeted the 3'-UTR of pyruvate dehydrogenase B (PDHB) and increased the consumption of glucose and the production of lactate. Overexpression of PDHB abolished the oncogenic effects of miR-203 on the growth of ovarian cancer cells. Together, our data suggested the oncogenic roles of miR-203 in ovarian cancer by promoting glycolysis, and miR-203 might be a therapeutic target for ovarian cancer.

Entities:  

Keywords:  Cell growth and migration; Glycolysis; MiR-203; Ovarian cancer; PDHB

Mesh:

Substances:

Year:  2016        PMID: 27655286     DOI: 10.1007/s13277-016-5415-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy.

Authors:  Wen Quan Jonathan Goh; Ghim Siong Ow; Vladimir A Kuznetsov; Shirly Chong; Yoon Pin Lim
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC.

Authors:  Daiwei Wan; Shunli Shen; Shunjun Fu; Burnley Preston; Coder Brandon; Songbing He; Chenglong Shen; Jian Wu; Sutong Wang; Wenxuan Xie; Bin Chen; A Liya; Yixing Guo; Dingcheng Zheng; Qiaoming Zhi; Baogang Peng
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

3.  miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis.

Authors:  Yan Shi; Yong-Jia Tan; Dong-Zhu Zeng; Feng Qian; Pei-Wu Yu
Journal:  Tumour Biol       Date:  2015-07-21

4.  p53 tumor suppressor gene mutation in ovarian cancer in Thai patients.

Authors:  Neelobol Neungton; Somchaya Neungton; Chairat Leelaphatanadit; Chongdee Dangrat; Rungthip Soiampornkul
Journal:  J Med Assoc Thai       Date:  2002-06

5.  MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.

Authors:  Jia-Quan Qu; Hong-Mei Yi; Xu Ye; Jin-Feng Zhu; Hong Yi; Li-Na Li; Ta Xiao; Li Yuan; Jiao-Yang Li; Yuan-Yuan Wang; Juan Feng; Qiu-Yan He; Shan-Shan Lu; Zhi-Qiang Xiao
Journal:  Mol Cancer Ther       Date:  2015-08-24       Impact factor: 6.261

6.  Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer.

Authors:  Shaosheng Wang; Xiaohong Zhao; Jie Wang; Yingmei Wen; Linjing Zhang; Dezhu Wang; Huili Chen; Qiuxia Chen; Wei Xiang
Journal:  Med Oncol       Date:  2013-08-07       Impact factor: 3.064

7.  miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells.

Authors:  Zhongxue Ye; Le Zhao; Jie Li; Wei Chen; Xu Li
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

8.  MicroRNA-203 negatively regulates c-Abl, ERK1/2 phosphorylation, and proliferation in smooth muscle cells.

Authors:  Guoning Liao; Reynold A Panettieri; Dale D Tang
Journal:  Physiol Rep       Date:  2015-09

9.  MicroRNA (miRNA) in cancer.

Authors:  Kaladhar B Reddy
Journal:  Cancer Cell Int       Date:  2015-04-02       Impact factor: 5.722

10.  Galectin-7 Regulates Keratinocyte Proliferation and Differentiation through JNK-miR-203-p63 Signaling.

Authors:  Hung-Lin Chen; Po-Cheng Chiang; Chia-Hui Lo; Yuan-Hsin Lo; Daniel K Hsu; Huan-Yuan Chen; Fu-Tong Liu
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

View more
  15 in total

1.  MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.

Authors:  Eva Karamitopoulou; Stefan Haemmig; Ulrich Baumgartner; Cornelia Schlup; Martin Wartenberg; Erik Vassella
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

2.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

3.  miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.

Authors:  Yuanzeng Zhu; Gang Wu; Wenfeng Yan; Han Zhan; Peichun Sun
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

4.  Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.

Authors:  Wenjia Zhang; Jing Su; Huadan Xu; Shanshan Yu; Yanan Liu; Yong Zhang; Liankun Sun; Ying Yue; Xiaoli Zhou
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

5.  Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.

Authors:  Jing Zhang; Dongdong Gao; Hui Zhang
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

Review 6.  Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications.

Authors:  Marco Ragusa; Cristina Barbagallo; Matilde Cirnigliaro; Rosalia Battaglia; Duilia Brex; Angela Caponnetto; Davide Barbagallo; Cinzia Di Pietro; Michele Purrello
Journal:  Front Mol Biosci       Date:  2017-10-04

7.  Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma.

Authors:  Rongqi He; Jintian Wang; Kai Ye; Jiabin Du; Junxing Chen; Weinan Liu
Journal:  Aging (Albany NY)       Date:  2019-12-16       Impact factor: 5.682

8.  Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer.

Authors:  Hongyu Xie; Wenjie Wang; Fengyu Sun; Kui Deng; Xin Lu; Huijuan Liu; Weiwei Zhao; Yuanyuan Zhang; Xiaohua Zhou; Kang Li; Yan Hou
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

9.  miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.

Authors:  Baojin Wang; Xia Li; Guannan Zhao; Huan Yan; Peixin Dong; Hidemichi Watari; Michelle Sims; Wei Li; Lawrence M Pfeffer; Yuqi Guo; Junming Yue
Journal:  J Exp Clin Cancer Res       Date:  2018-09-21

10.  MicroRNA‑665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10.

Authors:  Jinhui Liu; Yi Jiang; Yicong Wan; Shulin Zhou; Sunita Thapa; Wenjun Cheng
Journal:  Mol Med Rep       Date:  2018-07-05       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.